DK1049674T3 - Fremgangsmåde til fremstilling af (-) cis-3-hydroxy-1-methyl-4-(2,4,6-trimethoxyphenyl) -piperidin - Google Patents

Fremgangsmåde til fremstilling af (-) cis-3-hydroxy-1-methyl-4-(2,4,6-trimethoxyphenyl) -piperidin

Info

Publication number
DK1049674T3
DK1049674T3 DK98966836T DK98966836T DK1049674T3 DK 1049674 T3 DK1049674 T3 DK 1049674T3 DK 98966836 T DK98966836 T DK 98966836T DK 98966836 T DK98966836 T DK 98966836T DK 1049674 T3 DK1049674 T3 DK 1049674T3
Authority
DK
Denmark
Prior art keywords
trimethoxyphenyl
piperidine
cis
hydroxy
methyl
Prior art date
Application number
DK98966836T
Other languages
English (en)
Inventor
Gerhard Breipohl
Juergen Michalowsky
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Application granted granted Critical
Publication of DK1049674T3 publication Critical patent/DK1049674T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/42Oxygen atoms attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/78Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK98966836T 1998-01-23 1998-12-18 Fremgangsmåde til fremstilling af (-) cis-3-hydroxy-1-methyl-4-(2,4,6-trimethoxyphenyl) -piperidin DK1049674T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19802449A DE19802449A1 (de) 1998-01-23 1998-01-23 Verfahren zur Herstellung von (-)cis-3-Hydroxy-1-methyl-4-(2,4,6-trimethoxypyhenyl)-piperidin
PCT/EP1998/008327 WO1999037615A1 (de) 1998-01-23 1998-12-18 Verfahren zur herstellung von (-)cis-3- hydroxy-1- methyl-4-(2, 4,6-trimethoxyphenyl)- piperidin

Publications (1)

Publication Number Publication Date
DK1049674T3 true DK1049674T3 (da) 2007-06-25

Family

ID=7855418

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98966836T DK1049674T3 (da) 1998-01-23 1998-12-18 Fremgangsmåde til fremstilling af (-) cis-3-hydroxy-1-methyl-4-(2,4,6-trimethoxyphenyl) -piperidin

Country Status (27)

Country Link
US (1) US6225473B1 (da)
EP (1) EP1049674B1 (da)
JP (1) JP4585116B2 (da)
KR (1) KR100567941B1 (da)
CN (1) CN1137096C (da)
AR (1) AR015218A1 (da)
AT (1) ATE355270T1 (da)
AU (1) AU762407B2 (da)
BR (1) BR9814774B1 (da)
CA (1) CA2318946C (da)
CY (1) CY1106511T1 (da)
CZ (1) CZ298852B6 (da)
DE (2) DE19802449A1 (da)
DK (1) DK1049674T3 (da)
ES (1) ES2281943T3 (da)
HK (1) HK1033319A1 (da)
HU (1) HU227928B1 (da)
IL (1) IL137422A (da)
NO (1) NO321933B1 (da)
NZ (1) NZ505897A (da)
PL (1) PL190790B1 (da)
PT (1) PT1049674E (da)
RU (1) RU2265595C2 (da)
SK (1) SK285883B6 (da)
TR (1) TR200002146T2 (da)
WO (1) WO1999037615A1 (da)
ZA (1) ZA99477B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6437136B2 (en) * 1998-01-23 2002-08-20 Aventis Pharma Deutschland Gmbh Process for the preparation of (−)cis-3-hydroxy-1-methyl-4-(2,4,6-trimethoxyphenyl)piperidine
DE19809649A1 (de) * 1998-03-06 1999-09-09 Hoechst Marion Roussel De Gmbh Verfahren zur enzymatischen Enantiomeren-Trennung von 3(R)- und 3(S)-Hydroxy-1-methyl-4-(2,4,6-trimethoxyphenyl)-1,2,3,6-tetrahydro-pyridin bzw. der Carbonsäureester
RU2717829C2 (ru) 2015-04-20 2020-03-26 Толеро Фармасьютикалз, Инк. Прогнозирование ответа на альвоцидиб с помощью анализа профиля митохондрий
ES2739749T3 (es) 2015-05-18 2020-02-03 Tolero Pharmaceuticals Inc Profármacos de alvocidib que tienen biodisponibilidad aumentada
WO2017024073A1 (en) 2015-08-03 2017-02-09 Tolero Pharmaceuticals, Inc. Combination therapies for treatment of cancer
WO2018094275A1 (en) 2016-11-18 2018-05-24 Tolero Pharmaceuticals, Inc. Alvocidib prodrugs and their use as protein kinase inhibitors
MX2019007332A (es) 2016-12-19 2019-11-18 Tolero Pharmaceuticals Inc Péptidos indicadores y métodos para caracterizar sensibilidad.
JP7196160B2 (ja) 2017-09-12 2022-12-26 スミトモ ファーマ オンコロジー, インコーポレイテッド Mcl-1阻害剤アルボシジブを用いた、bcl-2阻害剤に対して非感受性である癌の治療レジメン
EP3890749A4 (en) 2018-12-04 2022-08-03 Sumitomo Dainippon Pharma Oncology, Inc. CDK9 INHIBITORS AND POLYMORPHS THEREOF FOR USE AS CANCER TREATMENT AGENT
US11793802B2 (en) 2019-03-20 2023-10-24 Sumitomo Pharma Oncology, Inc. Treatment of acute myeloid leukemia (AML) with venetoclax failure
CN110577974B (zh) * 2019-09-10 2021-07-20 杭州澳赛诺生物科技有限公司 手性3-羟基-1,2,3,6-四氢吡啶的合成方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN164232B (da) * 1986-04-11 1989-02-04 Hoechst India
DE3836676A1 (de) * 1988-10-28 1990-05-03 Hoechst Ag Die verwendung von 4h-1-benzopyran-4-on-derivaten, neue 4h-1-benzopyran-4-on-derivate und diese enthaltende arzneimittel
US5284856A (en) * 1988-10-28 1994-02-08 Hoechst Aktiengesellschaft Oncogene-encoded kinases inhibition using 4-H-1-benzopyran-4-one derivatives
US5849733A (en) * 1996-05-10 1998-12-15 Bristol-Myers Squibb Co. 2-thio or 2-oxo flavopiridol analogs
US5908934A (en) * 1996-09-26 1999-06-01 Bristol-Myers Squibb Company Process for the preparation of chiral ketone intermediates useful for the preparation of flavopiridol and analogs

Also Published As

Publication number Publication date
PL190790B1 (pl) 2006-01-31
DE19802449A1 (de) 1999-07-29
KR20010024867A (ko) 2001-03-26
NO321933B1 (no) 2006-07-24
ATE355270T1 (de) 2006-03-15
NO20003454L (no) 2000-07-04
BR9814774B1 (pt) 2010-10-05
AR015218A1 (es) 2001-04-18
SK10972000A3 (sk) 2000-12-11
AU762407B2 (en) 2003-06-26
CA2318946C (en) 2009-11-03
BR9814774A (pt) 2000-11-14
US6225473B1 (en) 2001-05-01
CN1284065A (zh) 2001-02-14
ES2281943T3 (es) 2007-10-01
KR100567941B1 (ko) 2006-04-07
HK1033319A1 (en) 2001-08-24
PL342064A1 (en) 2001-05-21
WO1999037615A1 (de) 1999-07-29
TR200002146T2 (tr) 2000-12-21
NO20003454D0 (no) 2000-07-04
IL137422A0 (en) 2001-07-24
CA2318946A1 (en) 1999-07-29
RU2265595C2 (ru) 2005-12-10
AU2513599A (en) 1999-08-09
EP1049674B1 (de) 2007-02-28
NZ505897A (en) 2003-03-28
PT1049674E (pt) 2007-04-30
HUP0100649A3 (en) 2002-12-28
IL137422A (en) 2005-11-20
HUP0100649A1 (hu) 2001-07-30
ZA99477B (en) 1999-09-23
CN1137096C (zh) 2004-02-04
CZ20002665A3 (cs) 2001-11-14
HU227928B1 (en) 2012-06-28
JP4585116B2 (ja) 2010-11-24
JP2002501048A (ja) 2002-01-15
SK285883B6 (sk) 2007-10-04
CZ298852B6 (cs) 2008-02-27
CY1106511T1 (el) 2012-01-25
EP1049674A1 (de) 2000-11-08
DE59813924D1 (de) 2007-04-12

Similar Documents

Publication Publication Date Title
IS5941A (is) Píperidín sem CCR5 stillar
ID28489A (id) Metode untuk membuat 4-karboksiamino-2-disubstitusi 1,2,3,4-tetrahidroquinolin
NO20032518L (no) Fremgangsmåte for fremstilling av amlodipinmaleat
DK1049674T3 (da) Fremgangsmåde til fremstilling af (-) cis-3-hydroxy-1-methyl-4-(2,4,6-trimethoxyphenyl) -piperidin
ID28601A (id) Proses penyiapan senyawa-senyawa 1,4-dihidropiridin
NO995851D0 (no) Fremstillingsfremgangsmåte for isoksasolidinedion forbindelse
DK1308454T3 (da) Fremgangsmåde til fremstilling af platinforbindelse
DK0856513T3 (da) Thalidomidanaloge forbindelser fra gruppen piperidin-2,6-dioner
ID26021A (id) Proses untuk menyiapan 1h-indole-3-glioksamida disubstitusi-4 1h-indole-glioksamida disubstitusi-4
DK1202949T3 (da) Fremgangsmåde til fremstilling af acylerede 1,3-dicarbonylforbindelser
ID26508A (id) Oksim-oksim tersubstitusi sebagai antagonis-antagonis neurokinin
DE59812284D1 (de) Verfahren zur Herstellung von 4-Amino-2,2,6,6-tetramethyl-piperidin
DK0949246T3 (da) Fremgangsmåde til fremstilling af phenoxyphenylsulfonylhalogenider
DE69714019D1 (de) 1,4-dihydropyridin-verbindungen als bradykinin-antagonisten
ITTO991117A0 (it) Procedimento per produrre 2,2,6,6-tetrametil-4-piperidone
NO20005743L (no) Fremgangsmåte til fremstilling av 4,5-epoksymorfinan-6- glukuronider
JP2001514250A5 (ja) カプロラクタムの製造法
NO20011309D0 (no) Benzotieno [3,2-c]pyridiner som<alfa>2-antagonister
IT1283793B1 (it) Processo per la preparazione di diidropiridine
ID27756A (id) Proses untuk memproduksi turunan-turunan benzopiran tersubstitusi 4
DK1296955T3 (da) Fremgangsmåde til fremstilling af 1,8-naphthalimid
DK0949237T3 (da) Fremgangsmåde til fremstilling af dihydrocitral
DK1104415T3 (da) Fremgangsmåde til fremstilling af 1,3-oxathiolan-nukleosider
DK0812843T3 (da) Fremgangsmåde til fremstilling af 2,3-pyridindicarboximider
IL120313A0 (en) Piperidine derivatives as neurokinin antagonists